Illumina Wins $27M Prenatal Test IP Verdict Against Ariosa
A California federal jury handed Illumina Inc a $26.7 million win against genomics company Ariosa Diagnostics Inc. on Thursday, finding Ariosa infringed two of its patents protecting prenatal testing technology....To view the full article, register now.
Already a subscriber? Click here to view full article